- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neoplasm, Bladder
Total 108671 results
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
University Hospital, RouenInstitut Curie; APHPRecruitingBladder Cancer | Chemotherapy EffectFrance
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Assiut UniversityUnknownBladder Cancer | Patient Satisfaction
-
University of Wisconsin, MadisonPfizerWithdrawn
-
UNC Lineberger Comprehensive Cancer CenterCompletedProstate Cancer | Bladder CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); OSI PharmaceuticalsCompletedBladder CancerUnited States
-
University of Michigan Rogel Cancer CenterCelgene CorporationCompletedBladder CancerUnited States
-
Queen Mary University of LondonGlaxoSmithKlineUnknownBladder CancerUnited Kingdom
-
University of VirginiaCompletedBladder CancerUnited States
-
Medical Research CouncilCompletedBladder CancerUnited Kingdom
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
Wales Cancer Trials UnitUnknownBladder CancerUnited Kingdom
-
Ankara Etlik City HospitalCompletedBladder Cancer | Bladder Cancer Stage I | Bladder Cancer Stage IITurkey
-
University of California, IrvineRecruitingMuscle-Invasive Bladder Cancer | Urothelial Bladder CancerUnited States
-
Istanbul Medeniyet UniversityRecruitingBladder Cancer Recurrent | Non-Invasive Bladder Urothelial CarcinomaTurkey
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
AstraZenecaParexelRecruitingNon-Muscle- Invasive Bladder CancerUnited States
-
University of Texas Southwestern Medical CenterRecruitingNon-muscle-invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
Predictive BiosciencesCompletedBladder Cancer RecurrenceUnited States
-
Applied Spectral Imaging Ltd.CompletedBladder CancersUnited States
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder CancerUnited States, Israel
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States
-
Binhui Biopharmaceutical Co., Ltd.RecruitingNon-muscle-invasive Bladder CancerChina
-
ImmunityBio, Inc.Active, not recruitingNon Muscle Invasive Bladder CancerUnited States
-
Five Prime Therapeutics, Inc.No longer available
-
Samsung Medical CenterActive, not recruitingMuscle-Invasive Bladder Carcinoma | Radical Cystectomy | Multiparametric MRI | Vesical Imaging Report and Data SystemKorea, Republic of
-
Ottawa Hospital Research InstituteAstraZeneca; Hamilton Health Sciences Corporation; London Health Sciences Centre and other collaboratorsRecruitingBladder CancerCanada
-
Baylor College of MedicineRecruitingBladder CancerUnited States
-
Daniel George, MDAstraZenecaWithdrawn
-
Institute of Cancer Research, United KingdomTrans Tasman Radiation Oncology GroupActive, not recruitingBladder CancerUnited Kingdom, New Zealand, Australia
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedBladder CancerUnited States
-
Seoul National University Bundang HospitalMSD Korea Ltd.CompletedNeuromuscular BlockadeKorea, Republic of
-
Yonsei UniversityCompletedProstate Cancer | Bladder CancerKorea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI); University of Southern California; NCIC Clinical...TerminatedBladder CancerUnited States, Canada
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb; Eli Lilly and Company; National Comprehensive Cancer NetworkCompletedBladder CancerUnited States
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedBladder CancerUnited States
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Matthew GalskyNovartisTerminatedBladder Cancer | Solid TumorsUnited States
-
Mount Vernon Cancer Centre at Mount Vernon HospitalCompletedBladder CancerUnited Kingdom
-
University of ChicagoNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
European Organisation for Research and Treatment...CompletedBladder CancerNetherlands, Belgium, France, Austria, United Kingdom, Israel, Italy, Turkey, Greece, Portugal, Romania
-
Sanjay Gandhi Postgraduate Institute of Medical...CompletedSurvival | Gall Bladder Carcinoma